Latest Revenue Growth News

Elsight Limited has reported a remarkable 344% jump in first-half revenue to US$4.85 million, significantly narrowing its net loss and securing a substantial US$39 million capital raise to fuel growth.

nib Group reported solid FY25 results with revenue growth to $3.6 billion and a 9.4% rise in net profit after tax, while maintaining its full-year dividend at 29 cents per share. The company’s Australian private health insurance business achieved record policyholder growth amid ongoing claims inflation and operational efficiencies.

nib holdings limited reported a 9.4% increase in net profit after tax to $198.6 million for FY25, alongside a 7.8% rise in group revenue to $3.6 billion. Despite a dip in underlying operating profit, the company declared a fully franked final dividend, maintaining its full-year payout at 29 cents per share.

Nuix Limited reported an 8% rise in Annualised Contract Value for FY25, driven by a remarkable 132% growth in its Nuix Neo platform. Despite flat revenue, the company achieved a 24.5% increase in Cash EBITDA and outlined a confident outlook for FY26.

Nuix Limited reported an 8% rise in Annualised Contract Value for FY25, powered by a surge in Nuix Neo sales, despite posting a net loss after tax. The company’s strategic pivot to higher-value contracts and technology restructuring sets the stage for FY26.

Lindsay Australia Limited reported a resilient FY25 with revenue up 5.6% to $849.8 million and underlying EBITDA of $81.4 million, despite margin pressures from competitive pricing and rising costs. The company successfully integrated the SRT acquisition, expanding its national refrigerated logistics network.

Nuix Limited reported a slight revenue increase to $221.5 million for FY25 but swung to a net loss of $9.2 million, weighed down by rising legal fees and restructuring costs. The company’s AI-driven Nuix Neo platform showed strong contract growth, while cash EBITDA improved significantly.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.

Lindsay Australia reported a 5.6% revenue increase in FY25, driven by strategic acquisitions and growth in transport and rural sectors, even as margins tightened amid competitive pressures and higher costs.

Lindsay Australia Limited reported a 5.6% revenue increase to A$849.8 million for FY25 but saw net profit after tax fall 36.2% to A$17.39 million. The company declared a fully franked final dividend of 1.5 cents per share and strengthened its national refrigerated logistics footprint through key acquisitions.

Felix Group Holdings reported a 21% revenue increase in FY25, driven by strong enterprise platform sales and positive cash flow, while strategically acquiring Nexvia to expand its SaaS footprint in construction.